What is the proper preparation and dosing for a magnesium sulfate intravenous drip in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Magnesium Sulfate Drip Preparation for Adults

For preeclampsia/eclampsia, prepare magnesium sulfate by adding 4-5 g to 250 mL of 5% dextrose or 0.9% normal saline and infuse over 15-20 minutes as a loading dose, followed by a maintenance infusion of 1-2 g/hour. 1

Standard Preparation Protocol

Loading Dose

  • Dilute 4-5 g magnesium sulfate in 250 mL of either 5% dextrose injection or 0.9% sodium chloride injection 1
  • Infuse over 15-20 minutes 2, 3
  • Alternative: 4 g IV can be given by diluting 50% solution to 10% or 20% concentration (40 mL of 10% solution or 20 mL of 20% solution) over 3-4 minutes 1

Maintenance Infusion

  • 1-2 g/hour by continuous IV infusion 1, 2
  • Continue for 24 hours postpartum or 24 hours after last seizure if eclampsia occurred 2
  • Target serum magnesium level: 1.8-3.0 mmol/L (therapeutic range) or 6 mg/100 mL for seizure control 1, 4

Critical Safety Parameters

Maximum Infusion Rate

  • Do not exceed 150 mg/minute (1.5 mL of 10% concentration) except in severe eclampsia with active seizures 1
  • Solutions for IV infusion must be diluted to 20% concentration or less prior to administration 1

Maximum Daily Dose

  • 30-40 g total over 24 hours in patients with normal renal function 1
  • 20 g over 48 hours maximum in severe renal insufficiency with frequent serum magnesium monitoring 1

Essential Monitoring Requirements

Before Each Dose Check

  1. Patellar reflex present (absent at 3.5-5 mmol/L) 1, 4
  2. Respiratory rate ≥16 breaths/minute (paralysis occurs at 5-6.5 mmol/L) 2, 1, 4
  3. Urine output ≥100 mL in preceding 4 hours 1

Toxicity Warning Signs (in order of severity)

  • Loss of deep tendon reflexes: 3.5-5 mmol/L 4
  • Respiratory depression: 5-6.5 mmol/L 4
  • Altered cardiac conduction: >7.5 mmol/L 4
  • Cardiac arrest: >12.5 mmol/L 4

Alternative Regimens by Indication

Low-Resource Settings (Preeclampsia)

  • Loading: 4 g IV or 10 g IM 2
  • Maintenance: 5 g IM every 4 hours until delivery and 24 hours postpartum 2

Severe Refractory Asthma

  • 2 g IV over 20 minutes as single dose 5
  • Combine with nebulized β-agonists and corticosteroids 5
  • Evidence shows moderate improvement in pulmonary function and reduced hospital admissions 6

Torsades de Pointes

  • 1-2 g IV over 15 minutes for recurrent episodes 7, 8
  • Maintain potassium ≥4.0 mmol/L and magnesium ≥2.0 mmol/L 8

Critical Contraindications & Precautions

Absolute Contraindications

  • Myasthenia gravis (relative)
  • Heart block
  • Severe renal impairment without dose adjustment 1

Drug Interactions Requiring Caution

  • CNS depressants (barbiturates, narcotics, anesthetics): reduce doses due to additive effects 1
  • Neuromuscular blocking agents: excessive block may occur 1
  • Cardiac glycosides: serious conduction changes possible; avoid calcium administration for toxicity 1
  • Antibiotics: may reduce activity of streptomycin, tetracycline, tobramycin 1

Antidote Preparation

Keep calcium gluconate 10% (1 g = 10 mL) immediately available to counteract magnesium toxicity 2, 1. Administer IV push over 3 minutes if respiratory depression or cardiac complications occur.

Common Pitfalls to Avoid

  1. Never use undiluted 50% solution IV - must dilute to ≤20% concentration 1
  2. Do not continue beyond 5-7 days in pregnancy - causes fetal skeletal abnormalities 1
  3. Reduce infusion rate if flushing/sweating occurs 1
  4. Limit concurrent IV fluids to 60-80 mL/hour in preeclampsia to avoid pulmonary edema 2
  5. Adjust dosing in elderly patients due to reduced renal function 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.